TELA Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of TELA Bio generated cash of -$40,857,000, which is less than the previous year. Cash used in financing activities reached the amount of $46,267,000 last year. Net change in cash is therefore $4,975,000.
Cash Flow
| 2017 | -16.36M | -101K | 26.33M |
|---|---|---|---|
| 2018 | -19.92M | -1.55M | 27.41M |
| 2019 | -25.52M | -11.98M | 65.53M |
| 2020 | -24.45M | 9.12M | 44.40M |
| 2021 | -30.43M | -627K | 585K |
| 2022 | -40.74M | -1.87M | 40.85M |
| 2023 | -40.85M | -599K | 46.26M |
TELA Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 42.01M | 43.93M | 74.39M | 45.30M | 17.27M | 11.34M | 1.48M |
Operating activities | |||||||
Net income | -46.66M | -44.29M | -33.27M | -28.79M | -22.42M | -21.09M | -21.33M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 808K | 1.18M | 535K | 525K | 582K | 1.24M | 761K |
Stock-based compensation expense | 5.03M | 3.98M | 3.66M | 2.05M | 457K | 0 | 197K |
| Deferred income tax benefit | 5.03M | 3.98M | 3.66M | 2.05M | 457K | 0 | 197K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -3.05M | -2.42M | -1.55M | 149K | -1.52M | -541K | -578K |
Inventories | -2.71M | -6.07M | -5.19M | -620K | -1.83M | -4.75M | -127K |
Accounts payable | 11K | -884K | 1.59M | -2.00M | -773K | 1.91M | -748K |
Cash generated by operating activities | -40.85M | -40.74M | -30.43M | -24.45M | -25.52M | -19.92M | -16.36M |
Investing activities | |||||||
Purchases Of Investments | 0 | -1M | 0 | 0 | -9.28M | 0 | 0 |
Investments In Property Plant And Equipment | -611K | -1.87M | -627K | -167K | -2.69M | -1.56M | -114K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 13K |
Cash generated by investing activities | -599K | -1.87M | -627K | 9.12M | -11.98M | -1.55M | -101K |
Financing activities | |||||||
Common Stock Issued | 46.34M | 34.4M | 585K | 44.72M | 51.15M | 0 | 14.13M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 34K | 0 | 0 | 0 |
Repayments of term debt | 0 | 10M | 0 | 0 | 0 | -18.73M | 12.19M |
Cash used in financing activities | 46.26M | 40.85M | 585K | 44.40M | 65.53M | 27.41M | 26.33M |
Net Change In Cash | 4.97M | -1.91M | -30.46M | 29.09M | 28.02M | 5.93M | 9.86M |
Cash at end of period | 46.99M | 42.01M | 43.93M | 74.39M | 45.30M | 17.27M | 11.34M |
| Data source | Data source | Data source | Data source | Data source |